Antiviral Clinical Trial for Long Covid-19

NCT06511063 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Long Covid

Interventions

DRUG: tenofovir disoproxil/emtricitabine
DRUG: Selzentry
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]
[object Object]